Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | IKBKB | O14920 | 2/20 | 0.54 |
| ▸ | MAP3K14 | Q99558 | 2/20 | 0.54 |
| ▸ | DHFR | P00374 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | REN | P00797 | 1/20 | 0.45 |
| ▸ | KMO | O15229 | 1/20 | 0.45 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.45 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Metoprine SCHEMBL29463675 | 1.00 | NPC1 (0.54) | NPC1RAB9AIKBKBMAP3K14DHFR | |
| Metoprine SCHEMBL4529657 | 0.98 | NPC1 (0.53) | NPC1RAB9AIKBKBMAP3K14DHFR | |
| SCHEMBL10999078 | 0.89 | ALDH1A1 (0.48) | NPC1RAB9AIKBKBMAP3K14DHFR | |
| SCHEMBL4535505 | 0.83 | HRH4 (0.47) | DHFRKMO | |
| SCHEMBL7271200 | 0.83 | HEXA (0.42) | NPC1RAB9ADHFRTP53CYP1A2 | |
| SCHEMBL7271143 | 0.83 | HEXA (0.42) | NPC1RAB9ADHFRTP53CYP1A2 | |
| SCHEMBL6049552 | 0.81 | IKBKB (0.49) | NPC1RAB9AIKBKBMAP3K14DHFR | |
| SCHEMBL11593238 | 0.81 | KMT2A (0.63) | NPC1RAB9AIKBKBMAP3K14DHFR | |
| SCHEMBL9485648 | 0.80 | NCOA1 (0.72) | DHFRTP53CYP1A2CYP3A4CYP2D6 | |
| Etoprine SCHEMBL3919 | 0.80 | DHFR (0.70) | DHFRTP53CYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11181 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122008213-A | Humanoid variable impedance control method based on man-machine stiffness mapping | 西安交通大学 | 2026-05-12 | — | — | CN | claimed |
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-12522572-B2 | Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-01-13 | — | — | US | claimed |
| US-20250275946-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | UNM RAINFOREST INNOVATIONS (US) | 2025-09-04 | — | — | US | claimed |
| US-20250213523-A1 | COMBINATION OF HDAC INHIBITORS AND STATINS FOR USE IN THE TREATMENT OF PANCREATIC CANCER | ISTITUTO NAZIONALE TUMORI IRCCS - FONDAZIONE G. PASCALE (IT) | 2025-07-03 | — | — | US | claimed |
| EP-4524131-A1 | SMALL MOLECULES FOR TREATING CANCER, INHABITING CHEMOKINE ACTIVITY AND/OR INDUCING CELL DEATH | AlonBio Ltd. (IL) | 2025-03-19 | — | — | EP | claimed |
| EP-4504165-A1 | COMBINATION OF HDAC INHIBITORS AND STATINS FOR USE IN THE TREATMENT OF PANCREATIC CANCER | Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale (IT) | 2025-02-12 | — | — | EP | claimed |
| US-12202803-B2 | Small molecules for treating cancer, inhibiting chemokine activity and/or inducing cell death | ALONBIO LTD. (IL) | 2025-01-21 | — | — | US | claimed |
| US-20240343697-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2024-10-17 | — | — | US | claimed |
| US-12109219-B2 | Cannabinoid receptor modulators | ARENA PHARMACEUTICALS, INC. (US) | 2024-10-08 | — | — | US | claimed |
| US-20060018933-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| CN-1634584-A | Anti-cancer medicine composition containing antimetabolite | SHANDONG LANJIN BIOENGINEERING (CN) | 2005-07-06 | — | — | CN | claimed |
| EP-1477165-A2 | Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis | Cornell Research Foundation, INC. (US) | 2004-11-17 | — | — | EP | claimed |
| US-20040092583-A1 | Treatment for inhibiting neoplastic lesions | SHANAHAN-PRENDERGAST ELIZABETH (IE) | 2004-05-13 | — | — | US | claimed |
| EP-1351678-A2 | TREATMENT FOR INHIBITING NEOPLASTIC LESIONS USING INCENSOLE AND/OR FURANOGERMACRENS | Shanahan-Prendergast, Elizabeth (IE) | 2003-10-15 | — | — | EP | claimed |
| WO-2002053138-A2 | TREATMENT FOR INHIBITING NEOPLASTIC LESIONS USING INCENSOLE AND/OR FURANOGERMACRENS | SHANAHAN-PRENDERGAST ELISABETH (IE) | 2002-07-11 | — | — | WO | claimed |
| EP-1154787-A2 | SYNERGISTIC COMBINATION FOR TREATMENT OF VIRAL-MEDIATED DISEASES | Institute of Molecular and Cell Biology (SG) | 2001-11-21 | — | — | EP | claimed |
| WO-2000050064-A2 | SYNERGISTIC COMBINATION FOR TREATMENT OF VIRAL-MEDIATED DISEASES | INSTITUTE OF MOLECULAR AND CELL BIOLOGY (SG) | 2000-08-31 | — | — | WO | claimed |
| US-4005204-A | Treatment of neoplasms in the brain with diamino dichloroalkyl pyrimidine | BURROUGHS WELLCOME CO. (US) | 1977-01-25 | — | — | US | claimed |
| US-4005203-A | Treatment of meningeal leukemia with diamino dichlorophenyl pyrimidine | BURROUGHS WELLCOME CO. (US) | 1977-01-25 | — | — | US | claimed |